(Q34280654)

1 August 2017

title

Myelin debris regulates inflammatory responses in an experimental demyelination animal model and multiple sclerosis lesions (English)

1 reference

1 August 2017

0 references

Tim Clarner

1

1 reference

1 August 2017

Felix Diederichs

2

1 reference

1 August 2017

Katharina Berger

3

1 reference

1 August 2017

Bernd Denecke

4

1 reference

1 August 2017

Lin Gan

5

1 reference

1 August 2017

Paul van der Valk

6

1 reference

1 August 2017

Cordian Beyer

7

1 reference

1 August 2017

Sandra Amor

8

1 reference

1 August 2017

Markus Kipp

9

1 reference

1 August 2017

publication date

11 June 2012

1 reference

1 August 2017

1 reference

1 August 2017

volume

60

1 reference

1 August 2017

issue

10

1 reference

1 August 2017

page(s)

1468-1480

1 reference

17beta-estradiol and progesterone prevent cuprizone provoked demyelination of corpus callosum in male mice

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22367

ADAM12 is expressed by astrocytes during experimental demyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22367

Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22367

Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22367

Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22367

Subpial demyelination in the cerebral cortex of multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22367

Selective regulation of growth factor expression in cultured cortical astrocytes by neuro-pathological toxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22367

Inflammatory demyelination is not central to the pathogenesis of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22367

T cells in multiple sclerosis and experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22367

Microglia: Intrinsic immuneffector cell of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22367

Cuprizone treatment induces distinct demyelination, astrocytosis, and microglia cell invasion or proliferation in the mouse cerebellum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22367

Astrocytes and microglia differentially regulate trafficking of lymphocyte subsets across brain endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22367

Endotoxin-activated microglia injure brain derived endothelial cells via NF-κB, JAK-STAT and JNK stress kinase pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22367

The cuprizone animal model: new insights into an old story

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22367

BLBP-expression in astrocytes during experimental demyelination and in human multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22367

Brain-region-specific astroglial responses in vitro after LPS exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22367

Cortical demyelination and diffuse white matter injury in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22367

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22367

Inflammatory cortical demyelination in early multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22367

The pathogenesis of multiple sclerosis: relating human pathology to experimental studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22367

Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22367

Multiple sclerosis: a complicated picture of autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22367

Effects of Fumaric Acids on Cuprizone Induced Central Nervous System De- and Remyelination in the Mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22367

Cuprizone treatment induces demyelination and astrocytosis in the mouse hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22367

Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22367

Cuprizone effect on myelination, astrogliosis and microglia attraction in the mouse basal ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22367

Microglial recruitment, activation, and proliferation in response to primary demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22367

The increasing incidence and prevalence of female multiple sclerosis--a critical analysis of potential environmental factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22367

Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22367

Myelin activates FAK/Akt/NF-kappaB pathways and provokes CR3-dependent inflammatory response in murine system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22367

Cytochemical and cytological properties of perineuronal oligodendrocytes in the mouse cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22367

Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22367

The blood-brain barrier in cortical multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22367

Enzymic activities and sodium, potassium and copper concentrations in mouse brain and liver after cuprizone treatment in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22367

Microglia potentiate damage to blood-brain barrier constituents: improvement by minocycline in vivo and in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22367

Association of Neocortical Volume Changes With Cognitive Deterioration in Relapsing-Remitting Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22367

Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22367

7 January 2021

The pathology of multiple sclerosis is location-dependent: no significant complement activation is detected in purely cortical lesions

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22367

7 January 2021

Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: increased yield of active demyelinating and (p)reactive lesions

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22367

7 January 2021

Grey matter pathology in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22367

7 January 2021

Epileptic seizures and hippocampal damage after cuprizone-induced demyelination in C57BL/6 mice

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22367

7 January 2021

Demyelination of the hippocampus is prominent in the cuprizone model

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22367

7 January 2021

The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22367

7 January 2021

Dynamics of production of MIP-1alpha, MCP-1 and MIP-2 and potential role of neutralization of these chemokines in the regulation of immune responses during experimental autoimmune neuritis in Lewis rats

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22367

7 January 2021

Identifiers

DOI

10.1002/GLIA.22367

1 reference

release_nabkq2tf3zd45ku3yfpxcxtenu

1 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nabkq2tf3zd45ku3yfpxcxtenu

24 November 2022

mapped directly with Wikidata item

1 reference